White Matter Microstructure Changes Revealed by Diffusion Kurtosis and Diffusion Tensor Imaging in Mutant Huntingtin Gene Carriers

被引:3
作者
Yin, Jin-Hui [1 ,2 ]
Liu, Ya-Ou [3 ]
Li, Hong-Liang [4 ]
Burgunder, Jean Marc [5 ]
Huang, Yue [1 ,2 ,6 ,7 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Human Brain & Tissue Bank, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China
[4] Aviat Gen Hosp, Dept Neurol, Beijing, Peoples R China
[5] Univ Hosp, Swiss Huntingtons Dis Ctr, Siloah, Dept Neurol, Gumligen Muri bei Bern, Switzerland
[6] Univ Hosp, Dept Neurol, Gumligen Muri bei Bern, Switzerland
[7] UNSW Sydney, Fac Med & Hlth, Sch Biomed Sci, Pharmacol Dept, Sydney, Australia
基金
中国国家自然科学基金;
关键词
Huntington's disease; diffusion kurtosis imaging; diffusion tensor imaging; mean kurtosis; fractional anisotropy; CAG-Age product; MILD COGNITIVE IMPAIRMENT; GAUSSIAN WATER DIFFUSION; DISEASE; PROGRESSION; PATHOLOGY; PREMANIFEST; DKI;
D O I
10.3233/JHD-240018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Diffusion magnetic resonance imaging (dMRI) has revealed microstructural changes in white matter (WM) in Huntington's disease (HD). Objective: To compare the validities of different dMRI, i.e., diffusion kurtosis imaging (DKI) and diffusion tensor imaging (DTI) in HD. Methods: 22 mutant huntingtin (mHTT) HTT ) carriers and 14 controls were enrolled. Clinical assessments and dMRI were conducted. Based on CAG-Age Product (CAP) score, m HTT carriers were categorized into high CAP (hCAP) and medium and low CAP (m& lCAP) groups. Spearman analyses were used to explore correlations between imaging parameters in brain regions and clinical assessments. Receiver operating characteristic (ROC) was used to distinguish m HTT carriers from control, and define the HD patients at advanced stage. Results: Compared to controls, mHTT carriers exhibited WM changes in DKI and DTI. There were 22 more regions showing significant differences in HD detected by MK than FA. Only MK in five brain regions showed significantly difference between any two group, and negatively correlated with the disease burden (r = -0.80 to -0.71). ROC analysis revealed that MK was more sensitive and FA was more specific, while Youden index showed that the integration of FA and MK gave rise to higher authenticities, in distinguishing m& lCAP from controls (Youden Index = 0.786), and discerning different phase of HD (Youden Index = 0.804). Conclusions: Microstructural changes in WM occur at early stage of HD and deteriorate over the disease progression. Integrating DKI and DTI would provide the best accuracies for differentiating early HD from control and identifying advanced HD.
引用
收藏
页码:301 / 313
页数:13
相关论文
共 64 条
[1]   MR biomarkers of degenerative brain disorders derived from diffusion imaging [J].
Andica, Christina ;
Kamagata, Koji ;
Hatano, Taku ;
Saito, Yuya ;
Ogaki, Kotaro ;
Hattori, Nobutaka ;
Aoki, Shigeki .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (06) :1620-1636
[2]   Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease [J].
Bardile, Costanza Ferrari ;
Garcia-Miralles, Marta ;
Caron, Nicholas S. ;
Rayan, Nirmala Arul ;
Langley, Sarah R. ;
Harmston, Nathan ;
Rondelli, Ana Maria ;
Teo, Roy Tang Yi ;
Waltl, Sabine ;
Anderson, Lisa M. ;
Bae, Han-Gyu ;
Jung, Sangyong ;
Williams, Anna ;
Prabhakar, Shyam ;
Petretto, Enrico ;
Hayden, Michael R. ;
Pouladi, Mahmoud A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (19) :9622-9627
[3]   Huntington disease [J].
Bates, Gillian P. ;
Dorsey, Ray ;
Gusella, James F. ;
Hayden, Michael R. ;
Kay, Chris ;
Leavitt, Blair R. ;
Nance, Martha ;
Ross, Christopher A. ;
Scahill, Rachael I. ;
Wetzel, Ronald ;
Wild, Edward J. ;
Tabrizi, Sarah J. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]   American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease (vol 16, e2, 2014) [J].
Bean, Lora ;
Bayrak-Toydemir, Pinar .
GENETICS IN MEDICINE, 2021, 23 (12) :2461-2461
[5]  
Beck A. T., BDI 2 BECK DEPRESSIO
[6]   Motor Abnormalities in Premanifest Persons with Huntington's Disease: The PREDICT-HD Study [J].
Biglan, Kevin M. ;
Ross, Christopher A. ;
Langbehn, Douglas R. ;
Aylward, Elizabeth H. ;
Stout, Julie C. ;
Queller, Sarah ;
Carlozzi, Noelle E. ;
Duff, Kevin ;
Beglinger, Leigh J. ;
Paulsen, Jane S. .
MOVEMENT DISORDERS, 2009, 24 (12) :1763-1772
[7]   Identification and characterization of Huntington related pathology: An in vivo DKI imaging study [J].
Blockx, Ines ;
Verhoye, Marleen ;
Van Audekerke, Johan ;
Bergwerf, Irene ;
Kane, Jack X. ;
Delgado y Palacios, Rafael ;
Veraart, Jelle ;
Jeurissen, Ben ;
Raber, Kerstin ;
von Hoersten, Stephan ;
Ponsaerts, Peter ;
Sijbers, Jan ;
Leergaard, Trygve B. ;
Van der Linden, Annemie .
NEUROIMAGE, 2012, 63 (02) :653-662
[8]   Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment [J].
Blockx, Ines ;
De Groof, Geert ;
Verhoye, Leen ;
Van Audekerke, Johan ;
Raber, Kerstin ;
Poot, Dirk ;
Sijbers, Jan ;
Osmand, Alexander P. ;
Von Hoersten, Stephan ;
Van der Linden, Annemie .
NEUROIMAGE, 2012, 59 (02) :957-967
[9]   Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease [J].
Bohanna, India ;
Georgiou-Karistianis, Nellie ;
Hannan, Anthony J. ;
Egan, Gary F. .
BRAIN RESEARCH REVIEWS, 2008, 58 (01) :209-225
[10]   Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes [J].
Cao, Ling-Xiao ;
Yin, Jin-Hui ;
Du, Gang ;
Yang, Qing ;
Huang, Yue .
BRAIN AND BEHAVIOR, 2024, 14 (03)